Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05216913 | Optimising Cardiovascular Health in Endometrial Cancer Survivors(OPTIMUS) | unknown | — | 80 | University of ManchesterOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT05812677 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 14, 2023 |
| clinicaltrials |
| NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | unknown | Phase 3 | 77 | Samsung Medical CenterOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05807672 | Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer(MARF-E) | unknown | — | 150 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT05793749 | Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy | unknown | N/A | 400 | Chongqing University Cancer HospitalOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT00492778 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | unknown | Phase 2 | 165 | GOG FoundationNETWORK | 2 | Mar 29, 2023 | clinicaltrials |
| NCT05783986 | Developing a MRI-based Deep Learning Model to Predict MMR Status | unknown | — | 600 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Mar 24, 2023 | clinicaltrials |
| NCT05755893 | Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 | unknown | — | 100 | Assiut UniversityOTHER | 0 | Mar 14, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05287048 | Evaluation of MCM5 in Postmenopausal Bleeding Patients | unknown | — | 2,000 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05707312 | Staging Endometrial caNcer Based on molEcular ClAssification | unknown | — | 1,032 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05634798 | An Observational Study Based on Endometrial Cancer Risk Screening Model | unknown | — | 2,000 | Peking Union Medical College HospitalOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05334303 | The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study | unknown | — | 400 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Nov 21, 2022 | clinicaltrials |
| NCT05588076 | Endometrial Lesions Predictions | unknown | — | 900 | Beijing Friendship HospitalOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT04995731 | Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer | unknown | — | 328 | Assiut UniversityOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04845425 | Analysis of miRNA Expression in Endometrial Cancer(MIRCE) | unknown | — | 150 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT03827837 | Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors | unknown | Phase 2 | 265 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05387460 | Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer | unknown | — | 2,000 | Tongji HospitalOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT02494791 | Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer(LS2) | unknown | N/A | 886 | University Health Network, TorontoOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT04866394 | Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS(SPARTACUS) | unknown | N/A | 40 | Sunnybrook Health Sciences CentreOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05273099 | Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma | unknown | — | 8 | Università degli Studi di FerraraOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT05290415 | Host DNA Methylation for Endometrial Cancer Screening | unknown | — | 10,000 | Lei LiOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05290922 | DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening | unknown | — | 7,150 | Lei LiOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT03570437 | Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?(COPELIA) | unknown | Phase 2 | 124 | University of ManchesterOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT05121363 | A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma | unknown | Phase 2 | 113 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Nov 30, 2021 | clinicaltrials |
| NCT04890912 | Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II(SPARTACUSII) | unknown | N/A | 50 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05056259 | Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients(PET/CT) | unknown | — | 42 | Assiut UniversityOTHER | 0 | Oct 25, 2021 | clinicaltrials |
| NCT00942357 | Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer | unknown | Phase 3 | 813 | Gynecologic Oncology GroupNETWORK | 3 | Oct 19, 2021 | clinicaltrials |
| NCT04290299 | Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive | unknown | — | 100 | National Cancer Institute, NaplesOTHER | 16 | Oct 13, 2021 | clinicaltrials |
| NCT04214964 | Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study | unknown | — | 10,000 | Tongji HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT02065687 | Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer | unknown | Phase 2 / Phase 3 | 469 | Gynecologic Oncology GroupNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT03570866 | PET/CT in the Management of Patients With Early Stage Endometrial Cancer(ENCA-1) | unknown | — | 40 | Università degli Studi dell'InsubriaOTHER | 0 | Sep 30, 2021 | clinicaltrials |
| NCT04867109 | HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding(METRODEC) | unknown | — | 100 | Nantes University HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT05026073 | Vibrational Spectroscopy for Endometrial Cancer Diagnosis(SPEED) | unknown | — | 150 | Nottingham University Hospitals NHS TrustOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT02512848 | The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period | unknown | — | 100 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT05018195 | Adipocytokines in Endometrial Cancer(ACEmCa) | unknown | N/A | 200 | National Taiwan University HospitalOTHER | 0 | Aug 24, 2021 | clinicaltrials |
| NCT04961775 | A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial Cancer | unknown | — | 277 | Chinese PLA General HospitalOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT04958278 | Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve(ENDO-GREEN) | unknown | — | 30 | University Hospital, BrestOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04665544 | Tracers for Endometrial Cancer Sentinel Node Labeling(TESLA-1) | unknown | N/A | 83 | University Medical Centre MariborOTHER | 3 | Jun 14, 2021 | clinicaltrials |
| NCT04836663 | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors | unknown | Phase 2 | 90 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jun 1, 2021 | clinicaltrials |
| NCT03951415 | Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer(DOMEC) | unknown | Phase 2 | 55 | Leiden University Medical CenterOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT03000192 | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | unknown | — | 3,000 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04787159 | Endometrial Cancer International Database(ECID) | unknown | — | 1,000 | Assiut UniversityOTHER | 0 | Mar 9, 2021 | clinicaltrials |
| NCT03207061 | Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? | unknown | N/A | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT03543215 | Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | unknown | — | 500 | Imperial College LondonOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT04251676 | Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis | unknown | — | 200 | National Taiwan University HospitalOTHER | 0 | Feb 11, 2021 | clinicaltrials |
| NCT04577950 | A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer(SENNAN) | unknown | N/A | 120 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT00501761 | Physical Activity After Endometrial Cancer | unknown | — | 326 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 31, 2020 | clinicaltrials |
Data updated 22 days agoSource updated May 16, 2023source: clinicaltrials